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QUALITY IMPROVEMENT 
Improving Chronic Pain Management Processes in 
Primary Care Using Practice Facilitation and Quality 
Improvement: The Central Appalachia Inter-Professional 
Pain Education Collaborative
The burden of chronic pain and opioid use has been felt throughout the United States. More than 12.5 million people age 12 or older misused pain relievers in 2015.1 Reactions vary among those who either defend or condemn the use of opioids for the management of chronic pain, a diagnosis that has 
nearly doubled over the past decade.2,3 Conscientious 
supporters of opioids remind us that there is a real 
threat of undertreating patients who experience pain and 
negatively impacting patients with mental disorders, 
causing a decline in overall function.4 Others contend that 
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Purpose  With the increasing burden of chronic pain and opioid use, provider shortages in Eastern Kentucky 
and West Virginia have experienced many challenges related to chronic pain management. This 
study tested a practice facilitator model in both academic and community clinics that selected and 
implemented best practice processes to better assist patients with chronic pain and increase the use 
of interdisciplinary health care services.
Methods  Using a quasi-experimental design, a practice facilitator was assigned to each state’s clinics and 
trained clinic teams in quality improvement methods to implement chronic pain tool(s) and workflow 
processes. Charts for 695 patients with chronic pain using opioids, from 8 randomly selected clinics in 
eastern Appalachia, were reviewed to assess for changes in clinic processes.
Results   Statistically significant improvements were found in 10 out of 16 chronic pain best practice process 
measures. These included improved workflow implementation (P<0.001), increased urine drug screen 
test orders (P=0.001) and increased utilization of controlled medication agreements (P=0.004). In total, 7 
of 8 clinics significantly improved in at least one, if not all, selected and implemented process measures.
Conclusions  Our findings indicate that practice facilitation, standardization of workflows and formation of structured 
clinical teams can improve processes of care in chronic pain management and facilitate the use of 
interdisciplinary services. Future studies are needed to assess long-term patient-centered outcomes that 
may result from improved processes of chronic pain care. (J Patient Cent Res Rev. 2017;4:247-255.)
Keywords  quality improvement, chronic pain, Appalachia, implementation, dissemination, primary care
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opiates are too easily abused, citing more than 20,100 
U.S. deaths in 2015 related to pain medication use.5-8
Although the prescribing of opioids for chronic pain 
has increased in various specialties, it is primary 
care providers who shoulder 40%–50% of U.S. 
opioid prescriptions.7,8 This is likely due to the fact 
that two-thirds of U.S. primary care visits are pain 
related.9 Yet, chronic pain management goes beyond 
the prescribing of opiates and includes other first-line 
nonpharmacologic and pharmacologic options.
The National Pain Strategy, a response to a 
congressional mandate of the National Institutes of 
Health, cites several reasons for the problems seen 
in opioid prescribing practices.9 One is that patients, 
the public and providers lack knowledge regarding 
appropriate and safe management of chronic pain.9 
With insufficient attention to pain management in 
medical education, primary care providers do not feel 
adequately trained for, and are often dissatisfied with, 
treating chronic pain patients, potentially leading to 
provider burn-out.10,11
Moreover, limited access to reimbursement for 
interprofessional care has been cited as a primary 
obstacle to addressing the opioid epidemic.12 The 
National Pain Strategy specifically highlights the 
need for increasing interprofessional care access, 
such as massage therapy, behavioral counseling and 
physical therapy, to reduce excessive dependence on 
opioids, and the authors concluded that coordination 
within the health care field and utilization of high-
quality team-based approaches will be necessary to 
effectively practice safe chronic pain management.13 
The multifaceted recommendations in chronic pain 
management guidelines include risk stratification, 
behavioral evaluations, informed consents, diagnostic 
testing and many other processes. Therefore, to 
succeed in implementation of chronic pain guidelines, 
a team-based approach may ensure that effective and 
sustainable strategies are in place to deliver safe pain 
management.
In general, translating guidelines into practice 
is a lengthy process. It takes an estimated 17 
years to proceed from initial discovery to clinical 
implementation.14 Barriers to the implementation of 
guidelines include provider-related factors (eg, lack of 
awareness, familiarity, interpretation or agreement).15 
One model to help accelerate implementation of 
guidelines into practice is a practice facilitator/
facilitation (PF) model, also known as quality 
improvement (QI) coaching. PFs support improvement 
efforts in clinics and help build organizational capacity 
for QI.16 A systematic review found PF contributed to 
increases in delivery of preventive services through 
improved communication and relationships within 
clinics.17 Another meta-analytic review found practices 
receiving PF were three times as likely as control 
practices to implement guidelines.18 Studies also found 
the effects from PF to be sustained for as long as 12 
months postintervention,19-22 with evidence of cost-
effectiveness.23 However, it remains unknown whether 
the effects of PF focused on using QI methods impacts 
clinical process measures in rural clinics caring for 
patients with chronic pain.
The Central Appalachia Inter-Professional Pain 
Education Collaborative (CAIPEC) was developed 
to improve practice performance in the treatment of 
chronic pain in rural primary care clinics in Kentucky 
and West Virginia through QI methods using PFs. 
Herein, we report the impact of the use of PFs in 
training and supporting teams in 8 rural clinics on 




A quasi-experimental pre/post implementation 
study was conducted in 2015–2016 to improve the 
clinic processes and care of patients with chronic 
pain. CAIPEC randomly recruited 20 primary care 
providers (physicians, physician assistants and nurse 
practitioners) across 8 clinics in Appalachia Kentucky 
and West Virginia. These clinics included 6 primary 
care clinics and 2 academic family medicine clinics. 
Eligible clinics were those that manage patients with 
chronic pain, defined as pain on most days lasting 
for at least 3 months,24 of which at least 20% of these 
patients were being managed with opioids. In addition, 
each provider included in the study had patients with 
chronic pain who were using opioids, whether managed 
by the provider or by a pain specialist.
 
The clinic population used in chart review 
assessments was comprised of patients who met 
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eligibility criteria, namely, those at least 21 years 
of age with documented generalized chronic pain 
who had the following diagnosed conditions: 1) low 
back pain (ICD-9 724.2); 2) back pain NOS (ICD-
9 724.4); 3) chronic pain (ICD-9 338.29, 338.4); or 
4) osteoarthrosis (ICD-9 715.00, 715.09, 715.90). In 
addition, these patients had to been seen for at least 
3 visits within a 12-month period by the providers 
participating in the study. Only patients who were 
currently managed with opioid medications as part 
of their chronic pain regimen were included in the 
chart review. This study was approved by both the 
University of Kentucky and West Virginia University 
institutional review boards.
Team Development and Engagement
A clinic champion was identified by each 
participating clinic, and a clinic QI team that included 
administrative and managerial office personnel, 
clinical management, nursing staff and health care 
providers was formed. A PF was available to each 
team and educated them in implementation processes 
and QI methods. There were two PFs working with 
their respective Kentucky and West Virginia clinics. 
The PFs attended training that was verified by the 
principal investigator based on the Agency for 
Healthcare Research and Quality (AHRQ) Practice 
Facilitation Handbook and associated competencies. 
These competencies included interpersonal skills 
to build support for and facilitate change, methods 
for accessing and using data to drive change, QI 




The Promoting Action on Research Implementation 
in Health Services (PARiHS) framework26 served as 
the mechanism by which the clinics implemented the 
chronic pain guidelines. The clinics chose aspects of 
the PARiHS framework that provided guidance on 
proactive and productive team-based processes. The 
PARiHS framework represents essential determinants 
of successful implementation of research into practice 
on three core elements: 1) the perceived strength of the 
evidence; 2) the context of the environment in which 
the intervention is implemented; and 3) the processes 
by which the implementation is facilitated.
Implementation Processes
Initial team meetings involved reviewing the evidence-
based chronic pain guidelines from the American Pain 
Society.27 Based on the PARiHS framework, discussions 
were focused on the perceived quality and applicability 
of the guideline. In addition, the team considered 
specific areas of potential improvement that they felt 
needed attention. These interactions and actions were 
documented in an implementation workbook accessible 
at http://www.cecentral.com/node/1266.
Subsequent meetings involved the PF instructing the 
clinic QI teams on implementation and QI processes, 
with meetings every 2–4 weeks and specific tasks to be 
completed before the next meeting. Tasks included such 
things as choosing the clinic team for implementation, 
completing study instruments (ie, Organizational 
Readiness to Change, provider knowledge survey, 
team participation and functioning survey, and specific 
toolkit pages), choosing a guideline to follow (ie, 
opioid treatment guidelines or CAIPEC chronic pain 
webcasts) and, finally, choosing which QI process the 
clinic will implement.
To establish current processes and workflows, the PF 
and clinic QI team conducted a detailed walk-through 
of the clinic experience and identified potential areas for 
improvement. The teams then developed a new workflow 
Figure 1.  Best practice process measures.
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based on these identified areas/processes. Clinic and 
team member responsibilities were then delineated and 
the clinic QI teams were educated on a Plan-Do-Study-
Act (PDSA) QI cycle.28 Again, the PF instructed the 
teams through this iterative PDSA process. The number 
of completed PDSA cycles was based on achieving a 
clinic’s particular process improvement goal, which was 
defined as implementing all aspects of the desired tasks 
for their chosen process change. Once all components of 
the new QI process were developed, a “go-live” date was 
established. Rapid assessments were further conducted 
to fine-tune the implementation process.
 
QI Process Selection
A “best practice” algorithm based on American Pain 
Society guidelines was developed as a menu of potential 
areas of improvement by the clinics (Figure 1). This 
includes such items as risk assessment, urine drug 
screening (UDS) and other recommended processes. 
Based on the baseline workflow assessments discussed 
previously, clinics chose one or more best practice 
process to implement for the project, allowing a 
pragmatic approach. That is, clinics selected the 
processes to improve upon based on the clinic’s own 
specific needs identified in the earlier walk-through 
exercise (Table 1).
 
Data Collection and Outcome Measures
PFs conducted chart reviews for outcome measures 
(discussed below) for each clinic at baseline and again 
at 3 months after the implementation (“go-live”) date. 
Clinic staff, and not the PF or research team, randomly 
selected charts if the patient met the aforementioned 
eligibility criteria. Charts were then verified for 
final inclusion criteria, as previously described, with 
subsequent data extraction by the PFs. Standardized data 
entry occurred utilizing web-based reporting through 
Research Electronic Data Capture (known as REDCap).
A sample size of 400 chart reviews was targeted based 
on estimated 20% improvement in process measures 
from baseline to postintervention (3 months) and a 
0.01 intracluster correlation coefficient to account for 
clustering effects. Due to variation in the numbers of 
providers in each clinic and to account for potential 
attrition, our goal was to conduct 20 chart reviews per 
provider for both the baseline period and the 3-month 
postintervention period for a total of 800 chart reviews. 
Since not all providers had a sufficient number of 
patients meeting eligibility criteria described above, 
a total of 695 chart reviews were conducted for the 
study, still achieving sufficient power. Baseline and 
postintervention chart reviews were composed of two 
 
Intervention Summary description Process measure
Clinic policy for controlled 
medications
Clinic implemented a controlled medications clinic protocol for new 
patients stating opioids would not be prescribed on first visit.
Use of a clinic opioid 
policy
Physical therapy (PT) 
quality reminder
Clinic implemented a PT quality reminder in the electronic health 
record system as a reminder to schedule PT appointments and 
follow-up appointments.
Use of integrative 
therapies
Urine drug screen (UDS) 
plan
Medical assistant reviewed charts day prior to clinic visit. If chart 
belonged to a chronic pain patient on opioids, the chart was flagged 
for UDS if needed. Care team and provider executed the UDS. Clinic 
nurse reviewed charts on Fridays to follow up on whether process 
was completed.




Medical assistant reviewed charts day prior to clinic visit. If chart 
belonged to a chronic pain patient on opioids, the chart was flagged 
for needed controlled medication agreement. Care team and provider 
executed agreement as needed. Licensed practical nurse reviewed 
charts on Fridays for follow-up on process.
Controlled medication 
agreement in chart
Pain Assessment and 
Documentation Tool (PADT)
Medical assistant reviewed charts day prior to clinic visit. If chart 
belonged to a chronic pain patient on opioids, the chart was flagged 
for needed PADT. Care team and provider executed PADT, referencing 
the "Potential Aberrant Drug-Related Behavior" section. Licensed 
practical nurse reviewed charts on Fridays for follow-up on process.
A risk assessment 
tool used
Table 1.  Sample of Process Interventions Chosen by One Participating Clinic
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independent cohorts (ie, “samples”) and not linked 
to the same patients. Hence, these samples were 
independent from one another.
 
The intent of the study was to assess changes in process 
measures related to chronic pain management and not 
patient clinical outcomes (ie, pain levels), since pre/post 
assessments were only 3 months apart. A comprehensive 
list of chronic pain process measures was assessed for 
each clinic regardless of the best practice process that 
was actually implemented by the clinic. The outcomes, 
aligned with the National Pain Strategy overarching 
plan, included presence of a clinic opioid policy, clinic 
workflow, a physical exam, UDS ordered within last 
12 months, a controlled medication agreement, use 
of nonopioid medications and integrative therapies, 
use of diagnostic testing, referral to specialists, use 
of pain-specific notes (ie, the Pain Assessment and 
Documentation Tool29), and whether goals were 
discussed with the patient. In addition, documentation 
of measured pain and use of mood disorder (GAD-730 
and PHQ-931), risk (Opioid Risk Tool32) and functional 
assessment (Pain Disability Index33) tools were reviewed. 
Other tools and resources that clinics could choose from 
can be found on the CAIPEC study website.
 
Statistical Analyses
Counts and frequencies were used to assess each process 
measure. Summative data were collated for all providers 
and clinics. Chi-squared analyses were performed to 
assess the pre/post impact of the QI procedures on each 
process. All analyses were conducted using Statistical 
Package for the Social Sciences (SPSS) Version 21 




Of the 20 providers, 75% were physicians and more 
than half reported they had practiced for 6–15 years; 
90% were registered with the U.S. Drug Enforcement 
Administration, and 80% reported being licensed to 
prescribe schedule 2 and schedule 3 medications (as 
advanced practice providers were included in the study). 
In addition 75% of providers reported writing at least 
one opioid prescription in the past 12 months, and 75% 
managed between 16 and 60 patients with chronic pain 
(Table 2). All providers and clinics that started the study 
were accounted for at study completion.
Process Outcomes
Overall, there were statistically significant 
improvements in 10 of 16 process measures across 
all 8 clinics (Table 3). While the 8 clinics targeted 
an average of 2.4 (range: 1-5) processes on which 
to improve during the study period, they in fact 
improved in 4.6 of 16 (range: 2-9) possible processes. 
Compared to baseline measures there was a 91% 
improvement in workflow implementation, a 12.9% 
increase in UDS tests ordered and a 10.7% increase 
in charted controlled medication agreements. 
Significant increases also were observed in the 
use of adjuvant medications (11.8%), integrative 
(massage, physical or behavioral) therapies (8.5%), 
and referrals to other specialists (16.1%). Substance 
abuse risk assessments also increased (11.9%), as did 
assessments of behavioral disorders (8.2%), pain level 
Characteristic n (%)
Health professional category
    Physician 15 (75%)
    Advanced practice nurse 1 (5%)
    Physician assistant 4 (20%)
DEA-registered
    Yes 18 (90%)
    No 2 (10%)
Licensed to prescribe schedule II/III medications
    Yes 16 (80%)
    No 4 (20%)
Written ≥ 1 opioid prescription in last year
    Yes 15 (75%)
    No 5 (25%)
Number of years in practice
    ≤5 4 (20%)
    6–10 9 (45%)
    11–15 3 (15%)
    16–20 1 (5%)
    21–25 1 (5%)
    >25 2 (10%)
Number of patients managed for chronic pain
    ≤5 1 (5%)
    6–15 3 (15%)
    16–30 6 (30%)
    31–60 9 (45%)
    61–100 1 (5%)
    >100 0
Table 2.  Provider Participant (N=20) Characteristics
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(15%) and function (16.2%). In fact, 7 of 8 clinics 
significantly improved in at least one, if not all, the 
process measures for which they chose to intervene 
(see boxed data in Table 3).
DISCUSSION 
The use of opioid analgesics for the treatment of 
chronic pain remains a contentious issue. This 
reflects a paradigm shift since the late 1980s when 
the undertreatment of pain became a public health 
concern,34 which subsequently catalyzed our current 
opioid epidemic.35 While the fears of harm –– abuse, 
misuse and overdose –– are genuine, many patients 
claim that opioids benefit them considerably. The 
outcomes of this project show that by using clinic QI 
team-based approaches with practice facilitation, we 
can positively affect clinic performance and the uptake 
of interdisciplinary health care services, including 
referrals to pain specialists and other integrative 
therapies such as physical therapy, behavioral health 
and massage therapy, in chronic pain management.
The burden of chronic pain management is often 
perceived by the primary care provider as his or her 
sole responsibility. This isolated approach can lead 
to provider burnout, stereotyping of pain patients 
and a low sense of confidence in managing patients 
with chronic pain. Specifically, such stereotyping can 
include lack of confidence in patient self-management 
and a stronger focus on psychological factors, which 
greatly affects the patient-centered approach to 
chronic pain management.11 A team-based approach 
distributes the actions required for comprehensive 
care by using the entire range of staff and providers 
within the clinic.
The CAIPEC implementation approach, with 
guidance by PFs, steered clinics to form structured 
clinical teams to improve their care processes for 
patients with chronic pain. The acceleration in clinic 
transformation by using PFs is based on improved 
organizational capacity for QI.16 Systematic reviews 
and other studies also have shown PF models 
to increase delivery of services by improving 
communication with sustainable effects.17,18 With 
the availability of training modules25 and certifying 
programs, it is possible for selected clinic staff to 
have their roles redefined to include PF training and 
competencies. Hence, this approach may be applicable 
 
to many community clinics, as current positions can 
be redefined without the need for hiring additional 
staff. Evidence suggests that practice facilitation is 
cost-effective in the long run.23
QI interventions within the primary care setting have 
shown the potential to benefit patients with chronic 
pain. However, high workloads in primary care offices 
serve as a common barrier to successfully implement 
such changes.36 With the use of a collaborative care 
intervention, Dobscha et al discovered significant 
improvements among primary care patients with 
chronic pain.36 The collaborative care intervention 
involved case management and internists who 
developed tailored care plans based on specific patient 
assessments, resulting in significant improvements 
in pain-related disability and pain intensity. This is 
promising, as our study only measured changes in 
process measures and not patient outcomes such as 
pain level. We were limited by a short follow-up period 
(3 months) after implementation, which is amenable to 
assessing changes in clinic processes but not patient-
centered outcomes.
 
While our study’s primary aim was to assess the impact 
of PF using QI methods to improve chronic pain 
management processes, there are other findings worth 
noting. Our study was conducted in two states (Kentucky 
and West Virginia) with provider regulations on opioid 
prescribing by their respective medical boards.37,38 Yet, 
baseline assessments of these clinics showed large 
gaps in expected care processes. For example, 4 of 8 
clinics had less than 50% of patients with a controlled 
medication agreement and 3 of 8 clinics had less than 
50% with a UDS in the previous 12 months. Therefore, 
these gaps reflect possible risk to providers and may 
serve as an incentive to participate in new approaches 




Several limitations should be noted in our quasi-
experimental design. Quasi-experimental designs are 
frequently used to evaluate interventions. Unlike a 
randomized control trial, the observed changes may be 
accounted for by other trends that were not studied.39 
CAIPEC was conducted in rural Appalachia, and its 




The use of a PF may have limited the generalizability 
of the intervention, as most primary care clinics do 
not have this resource or capability. Nonetheless, we 
believe that clinics have an opportunity to repurpose 
selected staff members to develop PF skills based on 
available modules and training programs. Moreover, the 
benefits demonstrated in our study serve as an impetus 
for organizations to justify funding such positions. 
Training can be found within The Practice Facilitation 
Handbook: Training Modules for New Facilitators and 
Their Trainers, published by AHRQ, or online at https://
pcmh.ahrq.gov/page/practice-facilitation.
We also acknowledge that since use of PF was part of 
the intervention, we were unable to assess whether QI 
methods alone would have yielded the same results. 
Since we only evaluated process changes over a 
3-month period, we are unable to assess patient-centered 
outcomes and sustainability of our intervention.
CONCLUSIONS 
This study demonstrated that a practice facilitation 
model may enhance quality improvement method 
implementation. Future multifaceted studies should 
focus on population- and practice-level interventions that 
assess both patient and provider behaviors and related 
outcomes. Such interventions are needed to increase the 
awareness of opioid risk and appropriate management 
of chronic pain through a team-based approach.
Patient-Friendly Recap
•  The practice of managing chronic pain through 
prescription opioids is contentious.
•  Rural clinics experiencing provider shortages 
often struggle to take a comprehensive 
approach to pain management, potentially 
resulting in overuse of opioids.
•  The authors studied whether the use of 
practice facilitators –– personnel trained in 
chronic pain tools and workflow processes 
–– would help enact quality improvement 
methods within clinics.
•  They found that interdisciplinary collaboration 
of care increased during the intervention 
and that numerous best practice measures 
improved.
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